| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 321915 | European Neuropsychopharmacology | 2010 | 7 Pages |
Abstract
Despite the size, burden and costs of anxiety disorders, many patients remain unrecognised, and the effectiveness of evidence-based interventions in routine clinical practice can be disappointing. The European College of Neuropsychopharmacology (ECNP) has established the ECNP Network Initiative (ECNP-NI) to help meet the goal of extending current understanding of the causes of central nervous system disorders, thereby contributing to improvements in clinical outcomes and reducing the associated societal burden. The Anxiety Disorders Research Network (ADRN) has been adopted within the ECNP-NI: this consensus statement summarises its overall aims and objectives.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
David S. Baldwin, Christer Allgulander, Alfredo Carlo Altamura, Jules Angst, Borwin Bandelow, Johan den Boer, Patrice Boyer, Simon Davies, Bernardo dell'Osso, Elias Eriksson, Naomi Fineberg, Mats Fredrikson, Andres Herran, Eduard Maron, Andres Metspalu,